PTAB challenges

Proceedings overview

Only one AIA trial proceeding, IPR2026-00043, has been filed against US Patent 7721282. This proceeding resulted in a discretionary denial of institution, meaning no claims were fully reviewed on their merits. Consequently, all claims of the patent remain untested by the PTAB. This status suggests a hardened defensive posture for the patent owner, as the patent has avoided a full merits review at the PTAB.

IPR2026-00043 — American Airlines, Inc. et al. v. Intellectual Ventures II LLC

• Type: Inter Partes Review
• Filed: 2025-10-10
• Status: Discretionary Denial. The Patent Trial and Appeal Board (PTAB) declined to institute the Inter Partes Review, terminating the proceeding before a full merits review of the challenged claims.
• Judge panel: The institution decision was a "Director Discretionary Decision," indicating that the Director of the USPTO, rather than a specific panel of Administrative Patent Judges (APJs), made the final decision regarding institution. The names of specific APJs on a panel are not publicly available for this decision through the provided search results.
• Petition grounds: The search results do not explicitly detail the specific claims challenged, the prior art asserted, or the statutory bases (§ 102 / § 103 / § 112) raised in the petition.
• Institution decision: Denied on 2026-02-02. The denial was a "Director Discretionary Decision" and the proceeding status is listed as "Not Instituted - Procedural". Recent policy changes, effective October 20, 2025, grant the USPTO Director the authority to decide whether to institute IPRs and PGRs. Additionally, Director Squires has issued guidance directing the PTAB to consider factors like U.S. manufacturing activity in institution decisions (March 2026) and has designated decisions as precedential where petitioners are perceived as seeking a "second bite at the apple" after district court litigation (May 2026). While the specific reasoning for this particular denial is not detailed beyond "procedural" in the public records, it aligns with a broader trend of discretionary denials under new USPTO Director policies.
• Final Written Decision: No Final Written Decision was issued because institution was denied.
• Settlement / termination: The proceeding was terminated on 2026-02-02 due to the discretionary denial of institution. There was no settlement.
• Appeal: No information regarding an appeal of the institution denial itself to the Federal Circuit is available in the provided search results. Generally, institution decisions are considered non-appealable under 35 U.S.C. § 314(d).
• Defensive value: This proceeding indicates that the patent survived an IPR petition without any claims being invalidated by the PTAB. A defendant facing assertion of this patent today should note that the claims have not been fully adjudicated by the PTAB, but that the patent owner successfully fended off one challenge at the institution phase, potentially due to the evolving discretionary denial policies at the PTAB.

Strategic summary

All claims of US7721282 remain UNTESTED by a full PTAB trial. The single IPR petition filed, IPR2026-00043 by American Airlines, Inc. et al., resulted in a discretionary denial of institution. This means the PTAB did not proceed to a full review of the patentability of the challenged claims, and therefore no claims were canceled or specifically sustained on their merits by the Board.

Regarding the estoppel landscape, 35 U.S.C. § 315(e)(2) statutory estoppel does not apply when institution of an IPR is denied. This means that the petitioner (American Airlines, Inc. et al.) and their privies would not be barred from raising any ground that was raised or reasonably could have been raised in the IPR in a subsequent district court proceeding or another PTAB proceeding. However, the concept of common law estoppel or the Director's discretion to deny institution based on parallel litigation or "second bite at the apple" doctrines could still impact future challenges. Given the denial was procedural, the prior-art grounds originally presented by American Airlines, Inc. et al. are still theoretically available to other defendants or in other forums, subject to the PTAB's current discretionary policies.

The denial of IPR2026-00043 reflects a pattern signaling a more patent-owner-friendly posture at the PTAB, particularly since late 2025 with the USPTO Director taking sole responsibility for institution decisions. The "Not Instituted - Procedural" status suggests the denial may be related to new policies aimed at limiting IPRs, especially those that might be duplicative of district court litigation or do not align with national policy objectives (like encouraging domestic manufacturing, as per Director Squires' March 2026 memo). This shift makes initiating IPRs more challenging for petitioners, particularly those without a U.S. manufacturing footprint or those perceived as engaging in serial or parallel challenges.

Recommended next steps

For a defendant currently facing assertion of US7721282, it's crucial to understand that while the patent has not had its claims invalidated at the PTAB, it also has not had them affirmed in a Final Written Decision. The discretionary denial of IPR2026-00043 means the claims were not fully vetted for patentability.

Since IPR2026-00043 was denied institution, there are no active trial-stage milestones (like institution decision deadlines, oral hearings, or FWD due dates) to track for this specific proceeding. The proceeding is closed. The denial decision itself, if made publicly available on the USPTO PTAB E2E portal, should be reviewed to understand the precise reasoning for the procedural denial, as this could inform strategy for any potential future PTAB challenges.

The absence of any granted IPRs or PGRs means that the patent's claims remain untested by the PTAB. This could be interpreted in several ways: either the claims are robust, or previous challenges have been deterred or dismissed on procedural grounds, as seen with IPR2026-00043. A potential defendant should carefully assess whether a new IPR petition could overcome the current discretionary denial policies, especially those related to parallel litigation or the "second bite" doctrine, given the ongoing district court cases.